Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060888) titled 'Estimation of the Prevalence of Celiac Disease Among Japanese Pediatric Patients Diagnosed With Irritable Bowel Syndrome or Functional Dyspepsia: A Multicenter Prospective Observational Study' on April 1.
Study Type:
Observational
Primary Sponsor:
Institute - Japanese Red Cross Kumamoto Hospital
Condition:
Condition - Irritable Bowel Syndrome and Functional Dyspepsia
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - The positive rate of serum anti-tissue transglutaminase IgA antibody (tTG-IgA) among pediatric patients diagnosed with IBS or FD according to Rome IV criteria.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 15
years-old
>
Gender - Male and Female
Key inclusion criteria - Japanese patients under 15-year-old age diagnosed as IBS according to Rome 4 criteria.
Japanese patients under 15-year-old age diagnosed as FD according to Rome 4 criteria.
Key exclusion criteria - Patients that physicians have deemed inappropriate due to their complications or treatment history.
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 28 Day
Anticipated trial start date - 2026 Year 04 Month 01 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069569
Disclaimer: Curated by HT Syndication.
